The research team behind a breakthrough in precision IBD therapy (IMAGE)
Caption
McMaster researchers are advancing a precision medicine approach to inflammatory bowel disease using bacteriophages to target harmful gut bacteria. Pictured (left to right): Kyle Jackson, Zeinab Hosseinidoust, associate professor and member of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR), and Elena Verdu, director of the Farncombe Family Digestive Health Research Institute and executive member of NexusHealth.
Credit
McMaster University
Usage Restrictions
None
License
Original content